CHICHY NWACHUKWU: Open Payments
NPI 1720628290 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,751 in 55 payments from 11 companies in 2025. Trend: 2023 $964 · 2024 $2,335 · 2025 $1,751
Food & beverage: $1,751
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 23 | $704 |
| Gilead Sciences, Inc. | 10 | $328 |
| Theratechnologies Inc. | 5 | $165 |
| GlaxoSmithKline, LLC. | 1 | $119 |
| Madrigal Pharmaceuticals | 1 | $107 |
| Merck Sharp & Dohme LLC | 4 | $88 |
| EMD Serono, Inc. | 4 | $75 |
| PFIZER INC. | 3 | $75 |
| Amgen Inc. | 2 | $39 |
| Hologic Sales and Service, LLC | 1 | $33 |
Products named: DOVATO, CABENUVA, EGRIFTA, Yeztugo, BLUJEPA, REZDIFFRA, PIFELTRO, PREVNAR 20.
Industry payments across TX — which companies pay providers there.
